Methylphenidate-induced impulsivity: Pharmacological antagonism by β-adrenoreceptor blockade

Journal of Psychopharmacology

Volumn 24, Issue 3, 2010, Pages 309-321

  Milstein, J A ^a   Dalley, J W ^a   Robbins, T W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

adrenoreceptors; 5 HT; Dopamine; Impulsivity; Methylphenidate

Indexed keywords

3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; AMPHETAMINE; BETA ADRENERGIC RECEPTOR; DOPAMINE; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR; METHYLPHENIDATE; NADOLOL; NORADRENALIN; PRAZOSIN; PROPRANOLOL; SAPORIN; SEROTONIN RECEPTOR; ADRENERGIC RECEPTOR BLOCKING AGENT; ANTI DOPAMINE BETA HYDROXYLASE IMMUNOTOXIN; ANTI-DOPAMINE BETA-HYDROXYLASE IMMUNOTOXIN; CENTRAL STIMULANT AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; MONOCLONAL ANTIBODY; RIBOSOME INACTIVATING PROTEIN 1; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DRUG RESPONSE; IMPULSIVENESS; LOCOMOTION; MALE; MENTAL TASK; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; ANIMAL; BRAIN; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERACTION; INSTRUMENTAL CONDITIONING; METABOLISM; RAT STRAIN;

ADRENERGIC ANTAGONISTS; ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; DOPAMINE ANTAGONISTS; DRUG INTERACTIONS; IMPULSIVE BEHAVIOR; MALE; METHYLPHENIDATE; NOREPINEPHRINE; RATS; RATS, INBRED STRAINS; RIBOSOME INACTIVATING PROTEINS, TYPE 1; SEROTONIN ANTAGONISTS;

EID: 77953043904     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108098146     Document Type: Article

References (57)

1. Abercrombie, ED, Zigmond, MJ (1989) Partial injury to central noradrenergic neurons: reduction of tissue norepinephrine content is greater than reduction of extracellular norepinephrine measured by microdialysis. J Neurosci 9: 4062-4067.
2. Alexander, BS, Wood, MD (1987) Stereoselective blockade of central [3H]5-hydroxytryptamine binding to multiple sites (5-HT1A, 5HT1B and 5-HT1C) by mianserin and propranolol. J Pharm Pharmacol 39: 664-666.
3. Alttoa, A, Eller, M, Herm, L, Rinken, A, Harro, J (2007) Amphetamine-induced locomotion, behavioral sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus. Brain Res 1131: 138-148. (Pubitemid 46053900)
4. Berridge, CW, Stratford, CL, Foote, SL, Kelley, AE (1997) Distribution of dopamine beta-hydroxylase-like immunoreactive fibers within the shell subregion of the nucleus accumbens. Synapse 27: 230-241.
5. Bizarro, L, Patel, S, Murtagh, C, Stolerman, IP (2004) Differential effects of psychomotor stimulants on attentional performance in rats: nicotine, amphetamine, caffeine and methylphenidate. Behav Pharmacol 15: 195-206. (Pubitemid 38859602)
6. Carli, M, Robbins, TW, Evenden, JL, Everitt, BJ (1983) Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9: 361-380. (Pubitemid 13002330)
7. Cole, BJ, Robbins, TW (1987) Amphetamine impairs the discriminative performance of rats with dorsal noradrenergic bundle lesions on a 5-choice serial reaction time task: new evidence for central dopaminergic-noradrenergic interactions. Psychopharmacology (Berl) 91: 458-466.
8. Cole, BJ, Robbins, TW (1989) Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal. Behav Brain Res 33: 165-179.
9. Cole, BJ, Robbins, TW (1992) Forebrain norepinephrine: role in controlled information processing in the rat. Neuropsychopharmacology 7: 129-142.
10. Cools, AR (1978) Haloperidol and the significance of alpha-NE mediated control of a subpopulation of DA receptors for concepts such as supersensitivity and tolerance: a behavioral study on cats. Life Sci 23: 2475-2483.
11. Darracq, L, Blanc, G, Glowinski, J, Tassin, JP (1998) Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J Neurosci 18: 2729-2739. (Pubitemid 28141818)
12. Devilbiss, DM, Berridge, CW (2006) Low-dose methylphenidate actions on tonic and phasic locus coeruleus discharge. J Pharmacol Exp Ther 319: 1327-1335.
13. Dews, PB (1977) The rate-dependency hypothesis. Science 198: 1182-1183.
14. Dreher, JK, Jackson, DM (1989) Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats. Brain Res 487: 267-277. (Pubitemid 19127195)
15. Drouin, C, Darracq, L, Trovero, F, Blanc, G, Glowinski, J, Cotecchia, S, et al. (2002) Alpha 1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J Neurosci 22: 2873-2884. (Pubitemid 37465836)
16. Drouin, C, Page, M, Waterhouse, B (2006) Methylphenidate enhances noradrenergic transmission and suppresses mid- and long-latency sensory responses in the primary somatosensory cortex of awake rats. J Neurophysiol 96: 622-632. (Pubitemid 44155202)
17. Filip, M, Nowak, E, Papla, I, Przegalinski. E (2001) Role of 5hydroxytryptaminelB receptors and 5-hydroxytryptamine uptake inhibition in the cocaine-evoked discriminative stimulus effects in rats. J Physiol Pharmacol 52: 249-263. (Pubitemid 32613039)
18. Gong, W, Neill, DB, Lynn, M, Justice Jr, JB (1999) Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site. Neuroscience 93: 1349-1358. (Pubitemid 29397563)
19. Granon, S, Passetti, F, Thomas, KL, Dalley, JW, Everitt, BJ, Robbins, TW (2000) Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci 20: 1208-1215. (Pubitemid 30220477)
20. Harrison, AA, Everitt, BJ, Robbins, TW (1997) Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology (Berl) 133: 329-342.
21. Howell, DC (1997) Statistical Methods for Psychology, fourth ed. London: Wadsworth.
22. Ikegami, M, Ichitani, Y, Takahashi, T, Iwasaki, T (2006) Compensatory increase in extracellular dopamine in the nucleus accumbens of adult rats with neonatal 6-hydroxydopamine treatment. Nihon Shinkei Seishin Yakurigaku Zasshi 26: 111-117. (Pubitemid 44098116)
23. Ikemoto, S, Glazier, BS, Murphy, JM, McBride, WJ (1997) Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward. J Neurosci 17: 8580-8587.
24. Ito, R, Robbins, TW, Everitt, BJ (2004) Differential control over cocaine-seeking behavior by nucleus accumbens core and shell. Nat Neurosci 7: 389-397. (Pubitemid 38429179)
25. Kim, JH, Kim, SY, Lee, SY, Jang, CG (2007) Antidepressant-like effects of Albizzia julibrissin in mice: involvement of the 5HT(1A) receptor system. Pharmacol Biochem Behav 87: 41-47.
26. Kuczenski, R, Segal, DS (2002) Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci 22: 7264-7271.
27. Kustanovich, V, Ishii, J, Crawford, L, Yang, M, McGough, JJ, McCracken, JT, et al. (2004) Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5. Mol Psychiatry 9: 711-717. (Pubitemid 38932176)
28. Lawler, CP, Prioleau, C, Lewis, MM, Mak, C, Jiang, D, Schetz, JA, et al. (1999) Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropsychopharmacology 20: 612-627. (Pubitemid 29189265)
29. Malhotra, AK, Virkkunen, M, Rooney, W, Eggert, M, Linnoila, M, Goldman, D (1996) The association between the dopamine D4 receptor (D4DR) 16 amino acid repeat polymorphism and novelty seeking. Mol Psychiatry 1; 388-391. (Pubitemid 126441322)
30. Milstein, JA, Lehman, O, Theobald, DE, Dalley, JW, Robbins, TW (2007) Selective depletion of cortical noradrenaline by antidopamine beta hydroxylase-saporin impairs attentional function and enhances the effects of guanfacine in the rat Psychopharmacology (Berl) 190: 51-93.
31. Murphy, ER, Robinson, ES, Theobald, DE, Dalley, JW, Robinson, TW (2008) Contrasting effects of selective lesions of nucleus accumbens core or shell on inhibitory control and amphetamine-induced impulsive behaviour. Eur J Neurosci 28: 353-363.
32. Navarra, R, Graf, R, Huang, Y, Logue, S, Comery, T, Hughes, Z, et al. (2008) Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Prog Neuropsychopharmacol Biol Psychiatry 32: 34-41.
33. Paine, TA, Tomasiewicz, HC, Zhang, K, Carlezon Jr, WA (2007) Sensitivity of the five-choice serial reaction time task to the effects of various psychotropic drugs in Sprague-Dawley rats. Biol Psychiatry 62: 687-693. (Pubitemid 47314378)
34. Parkinson, JA, Olmstead, MC, Burns, LH, Robbins, TW, Everitt, BJ (1999) Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by D-amphetamine. J Neurosci 19: 2401-2411.
35. Pascoli, V, Valjent, E, Corbille, AG, Corvol, JC, Tassin, JP, Girault, JA, et at. (2005) cAMP and ERK signaling in response to Damphetamine and methylphenidate in the prefrontal cortex in vivo: role of {beta}1-adrenoceptors. Mol Pharmacol 68: 421-429.
36. Passetti, F, Levita, L, Robbins, TW (2003) Sulpiride alleviates the attentional impairments of rats with medial prefrontal cortex lesions. Behav Brain Res 138: 59-69. (Pubitemid 35463237)
37. Patel, S, Freedman, S, Chapman, KL, Emms, F, Fletcher, AE, Knowles, M, et al. (1997) Biological profile of L-745, 870, a selective antagonist with high affinity for the dopamine D4 receptor. J Pharmacol Exp Ther 283: 636-647.
38. Pattij, T, Janssen, MC, Vanderschuren, LJ, Schoffelmeer, AN, van Gaalen, MM (2007) Involvement of dopamine D1 and D2 receptors in the nucleus accumbens core and shell in inhibitory response control. Psychopharmacology (Berl) 191: 587-598. (Pubitemid 46355887)
39. Pezze, MA, Dalley, JW, Robbins, TW (2007) Differential roles of dopamine D1 and D2 receptors in the nucleus accumbens in attentional performance on the five-choice serial reaction time task. Neuropsychopharmacology 32: 273-283.
40. Poncelet, M, Chermat, R, Soubrie, P, Simon, P (1983) The progressive ratio schedule as a model for studying the psychomotor stimulant activity of drugs in the rat. Psychopharmacology (Berl) 80: 184-189.
41. Puumala, T, Ruotsalainen, S, Jakala, P, Koivisto, E, Riekkinen Jr, P, Sirvio, J (1996) Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder. Neurobiol Learn Mem 66: 198-211.
42. Reisine, TD, Chesselet, MF, Lubetzki, C, Cheramy, A, Glowinski, J (1982) A role for striatal beta-adrenergic receptors in the regulation of dopamine release. Brain Res 241: 123-130. (Pubitemid 12124936)
43. Robinson, ES, Eagle, DM, Mar, AC, Bari, A, Banerjee, G, Jiang, X, et al. (2008) Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 33: 1028-1037.
44. Rivera, A, Cuellar, B, Giron, FJ, Grandy, DK de la, CA, Moratalla, R (2002) Dopamine D4 receptors are heterogeneously distributed in the striosomes/matrix compartments of the striatum. J Neurochem 80: 219-229.
45. Salmon, P, Gray, JA (1985a) Comparison between the effects of propranolol and chlordiazepoxide on timing behaviour in the rat Psychopharmacology (Berl) 87: 219-224.
46. Salmon, P, Gray, JA (1985b) Opposing acute and chronic behavioural effects of a beta-blocker, propranolol, in the rat. Psychopharmacology (Berl) 86: 480-486.
47. Schank, JR, Ventura, R, Puglisi-Allegra, S, Alcaro, A, Cole, CD, Liles, LC, et al. (2006) Dopamine beta-hydroxylase knockout mice have alterations in dopamine signaling and are hypersensitive to cocaine. Neuropsychopharmacology 31: 2221-2230.
48. Schiff, AA, Saxey, A (1984) Autoradiography of nadolol and propranolol in the rat. Xenobiotica 14: 687-691.
49. Schinka, JA, Letsch, EA, Crawford, FC (2002) DRD4 and novelty seeking: results of meta-analyses. Am J Med Genet 114: 643-648.
50. Short, PH, Shuster, L (1976) Changes in brain norepinephrine associated with sensitization to d-amphetamine. Psychopharmacology (Berl) 48: 59-67.
51. Tuinstra, T, Cools, AR (2000) High and low responders to novelty: effects of adrenergic agents on the regulation of accumbal dopamine under challenged and non-challenged conditions. Neuroscience 99: 55-64.
52. van Gaalen, MM, Brueggeman, RJ, Bronius, PF, Schoffelmeer, AN, Vanderschuren, LJ (2006) Behavioral disinhibition requires dopamine receptor activation. Psychopharmacology (Berl) 187: 73-85.
53. Vanderschuren, LJ, Beemster, P, Schoffelmeer, AN (2003) On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization. Psychopharmacology (Berl) 169: 176-185.
54. Weinshenker, D, Miller, NS, Blizinsky, K, Laughlin, ML, Palmiter, RD (2002) Mice with chronic norepinephrine deficiency resemble amphetamine- sensitized animals. Proc Natl Acad Sci U S A 99: 13873-13877.
55. Winstanley, CA, Chudasama, Y, Dalley, JW, Theobald, DE, Glennon, JC, Robbins, TW (2003) Intra-prefrontal 8-OH-DPAT and M 100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats. Psychopharmacology (Berl) 167: 304-314.
56. Zhang, K, Davids, E, Tarazi, FI, Baldessarini, RJ (2002a) Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions. Psychopharmacology (Berl) 161: 100-106. (Pubitemid 34437975)
57. Zhang, K, Tarazi, FI, Davids, E, Baldessarini, RJ (2002b) Plasticity of dopamine D4 receptors in rat forebrain: temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning. Neuropsychopharmacology 26: 625-633. (Pubitemid 34260981)